The BioPharma Industry in 2015
As Good as it Gets
2015 has had a spectacular run! This presentation reviews what we've accomplished, and peaks around the curve at what may lie ahead.
2015 has had a spectacular run: $145 billion in alliances with announced payments of $50 million or more from 2012-15, plus 375 acquisitions and asset purchases totaling more than $865 billion over the same period. Then there’s the 186 Initial Public Offerings on US exchanges since January 2013, raising $14 billion and constituting our longest “IPO window” by far. This presentation reviews what we’ve accomplished, and peaks around the curve at what may lie ahead.